Literature DB >> 27504608

Dedicator of Cytokinesis 2 in Cell Signaling Regulation and Disease Development.

Xia Guo1, Shi-You Chen1.   

Abstract

Dedicator of cytokinesis 2 (DOCK2) is a CDM family protein containing DOCK homology region (DHR)-1 and DHR-2, Src-homology 3 (SH3) domain, and C-terminal polybasic amino acid cluster. The CDM family consists of 11 mammalian members and is classified into four subfamilies, the DOCK-A, -B, -C, and -D. DOCK2 is a member of DOCK-A subfamily and an atypical guanine exchange factor regulating the loading of GTP to activate Rac. It is primarily found in peripheral blood, spleen, and thymus and mainly expressed in lymphocytes and macrophages of various organs. DOCK2 is also expressed in microglial in brain and is induced in neointima smooth muscle following vascular injury. Functionally, DOCK2 is involved in cell motility, polarity, adhesion, proliferation, and apoptosis. It is essential for lymphocyte migration and activation as well as neutrophil chemotaxis. DOCK2 also regulates the differentiation of natural killer T cells, type 2 T helper cells, and plasmacytoid dendritic cells. In addition, it is important for the growth of B cell lymphoma and prostate cancer cells. Deletion of DOCK2 enables long-term cardiac allograft survival. Moreover, DOCK2 is associated with the Alzheimer Disease, HIV development, and the early-onset of invasive infections. Recently, we found that DOCK2 plays a critical role in SMC phenotypic modulation and vascular remodeling. In this review, we will briefly summarize recent advancement of DOCK2 function. J. Cell. Physiol. 232: 1931-1940, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27504608     DOI: 10.1002/jcp.25512

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  16 in total

1.  YAP Partially Reprograms Chromatin Accessibility to Directly Induce Adult Cardiogenesis In Vivo.

Authors:  Tanner O Monroe; Matthew C Hill; Yuka Morikawa; John P Leach; Todd Heallen; Shuyi Cao; Peter H L Krijger; Wouter de Laat; Xander H T Wehrens; George G Rodney; James F Martin
Journal:  Dev Cell       Date:  2019-02-14       Impact factor: 12.270

2.  Novel PDGFRB fusions in childhood B- and T-acute lymphoblastic leukemia.

Authors:  A M Heilmann; A B Schrock; J He; M Nahas; K Curran; N Shukla; S Cramer; L Draper; A Verma; R Erlich; J Ross; P Stephens; V A Miller; S M Ali; J-A Verglio; M S Tallman; T I Mughal
Journal:  Leukemia       Date:  2017-05-29       Impact factor: 11.528

3.  DOCK2 Promotes Pleural Fibrosis by Modulating Mesothelial to Mesenchymal Transition.

Authors:  Guoqing Qian; Oluwaseun Adeyanju; Saptarshi Roy; Christudas Sunil; Ann Jeffers; Xia Guo; Mitsuo Ikebe; Steven Idell; Torry A Tucker
Journal:  Am J Respir Cell Mol Biol       Date:  2022-02       Impact factor: 6.914

4.  Dedicator of Cytokinesis 2 (DOCK2) Deficiency Attenuates Lung Injury Associated with Chronic High-Fat and High-Fructose Diet-Induced Obesity.

Authors:  Guoqing Qian; Oluwaseun Adeyanju; Christudas Sunil; Steven K Huang; Shi-You Chen; Torry A Tucker; Steven Idell; Xia Guo
Journal:  Am J Pathol       Date:  2021-11-10       Impact factor: 4.307

5.  DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition.

Authors:  Xia Guo; Oluwaseun Adeyanju; Christudas Sunil; Venkatakirankumar Mandlem; Ayobami Olajuyin; Steven Huang; Shi-You Chen; Steven Idell; Torry A Tucker; Guoqing Qian
Journal:  Am J Physiol Cell Physiol       Date:  2022-05-18       Impact factor: 5.282

6.  Genetic variants of DOCK2, EPHB1 and VAV2 in the natural killer cell-related pathway are associated with non-small cell lung cancer survival.

Authors:  Hailei Du; Lihua Liu; Hongliang Liu; Sheng Luo; Edward F Patz; Carolyn Glass; Li Su; Mulong Du; David C Christiani; Qingyi Wei
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

7.  DOCK2 deficiency mitigates HFD-induced obesity by reducing adipose tissue inflammation and increasing energy expenditure.

Authors:  Xia Guo; Feifei Li; Zaiyan Xu; Amelia Yin; Hang Yin; Chenxiao Li; Shi-You Chen
Journal:  J Lipid Res       Date:  2017-07-17       Impact factor: 5.922

Review 8.  The DOCK protein family in vascular development and disease.

Authors:  Clare E Benson; Laura Southgate
Journal:  Angiogenesis       Date:  2021-02-06       Impact factor: 10.658

9.  FLT3-ITD cooperates with Rac1 to modulate the sensitivity of leukemic cells to chemotherapeutic agents via regulation of DNA repair pathways.

Authors:  Min Wu; Li Li; Max Hamaker; Donald Small; Amy S Duffield
Journal:  Haematologica       Date:  2019-04-11       Impact factor: 9.941

10.  LMDIPred: A web-server for prediction of linear peptide sequences binding to SH3, WW and PDZ domains.

Authors:  Debasree Sarkar; Tanmoy Jana; Sudipto Saha
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.